We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock
ODT

Delisted

ODT was delisted on the 14th of January, 2022.

Back to rankings

77 hedge funds and large institutions have $1.14B invested in Odonate Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 15

111% more capital invested

Capital invested by funds: $541M → $1.14B (+$599M)

35% more funds holding

Funds holding: 57 → 77 (+20)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

Holders
77
Holders Change
+20
Holders Change %
+35.09%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
21
Increased
34
Reduced
15
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$50.5M
2
TCM
Tang Capital Management
California
+$23.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.1M
4
EAM
Eagle Asset Management
Florida
+$12M
5
CTA
Carillon Tower Advisers
Florida
+$11M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.41M
2
Franklin Resources
Franklin Resources
California
-$1.81M
3
Morgan Stanley
Morgan Stanley
New York
-$746K
4
Allianz Asset Management
Allianz Asset Management
Germany
-$672K
5
JP Morgan Chase
JP Morgan Chase
New York
-$622K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$2.9M +$39.2K +1,637 +2%
Artisan Partners
27
Artisan Partners
Wisconsin
$2.79M +$1.82M +76,000 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$2.57M – – –
GTC
29
Ghost Tree Capital
New York
$2.38M +$1.56M +65,000 New
Charles Schwab
30
Charles Schwab
California
$2.03M +$27.6K +1,150 +2%
Allianz Asset Management
31
Allianz Asset Management
Germany
$1.98M -$672K -28,033 -34%
OAM
32
Oxford Asset Management
United Kingdom
$1.8M +$651K +27,185 +124%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$1.39M -$52.6K -2,194 -5%
Renaissance Technologies
34
Renaissance Technologies
New York
$1.14M +$280K +11,700 +61%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.13M +$182K +7,608 +33%
CIP
36
Chartwell Investment Partners
Pennsylvania
$1.12M +$42.7K +1,782 +6%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.04M +$248K +10,331 +57%
N
38
Nuveen
North Carolina
$786K +$513K +21,401 New
BC
39
Birchview Capital
Vermont
$734K – – –
MIM
40
Monashee Investment Management
Massachusetts
$734K +$479K +20,000 New
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$734K +$479K +20,009 New
SO
42
STRS Ohio
Ohio
$543K +$309K +12,900 +679%
EGM
43
Engineers Gate Manager
New York
$513K +$335K +13,984 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$499K +$91.1K +3,800 +39%
OWIM
45
Old West Investment Management
California
$498K -$1.1K -46 -0.3%
JP Morgan Chase
46
JP Morgan Chase
New York
$495K -$622K -25,965 -65%
Swiss National Bank
47
Swiss National Bank
Switzerland
$455K +$297K +12,400 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$438K +$39.4K +1,646 +16%
Squarepoint
49
Squarepoint
New York
$376K +$246K +10,256 New
Millennium Management
50
Millennium Management
New York
$375K +$245K +10,226 New
1
2
3 4

ODT Hedge Fund Activity: Q2 2019 in Review

77 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q2 2019, worth a combined $1.14B — up 111% from $541M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ODT positions and 0 closed out — a net gain of 21 holders — while 34 added to existing stakes and 15 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $50.5M. The largest seller was Sabby Management, cutting an estimated $2.41M.

  • 77 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q2 2019, up from 57 in Q1 2019.
  • Funds reported $1.14B of Odonate Therapeutics, Inc. Common Stock stock for Q2 2019, up 111% quarter-over-quarter.
  • 21 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q2 2019 and 0 closed out, a net change of +21 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock buyer in Q2 2019 was Wellington Management Group, an estimated $50.5M added.
  • The largest Odonate Therapeutics, Inc. Common Stock seller in Q2 2019 was Sabby Management, an estimated $2.41M sold.

Based on aggregated 13F filings for Q2 2019.